300+ investors in your industry, stage, and region Get
Any industry
Big Data
Video Games
Clean Energy
Google
Construction
Hospitality
EdTech
Consumer
Artificial Intelligence
Local
Enterprise Software
Platforms
Travel
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
Film
Payments
Photography
Email
CleanTech
Energy
Marketplace
SaaS
Restaurants
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Education
Wellness
Medical Device
Mobile
Sports
Legal
Automotive
eSports
Biotechnology
Software
Renewable Energy
Theatre
Crowdfunding
Recruiting
Web3
Medical
Infrastructure
Beauty
Fashion
Venture Capital
Social
LGBT
Cannabis
Climate
Celebrity
Wine and Spirits
Food and Beverage
Publishing
Life Science
Mobile Apps
Music
Real Estate
Sporting Goods
Art
Digital Media
FinTech
Manufacturing
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Biotech
Sustainability
Transportation
Proptech
Impact
Hardware
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
United Kingdom
Hong Kong
Thailand
United Arab Emirates
Greece
Benin
Croatia
Japan
South Korea
Burkina Faso
Africa
Brazil
Singapore
Oceania
LATAM
Gibraltar
Egypt
Kyrgyzstan
Zambia
Zimbabwe
Liberia
Malawi
Sweden
Mexico
Nigeria
Russian Federation
Togo
Nepal
Guinea
Haiti
Iran
Isle of Man
Lesotho
Madagascar
Pakistan
Romania
Taiwan
Norway
Tajikistan
Tunisia
Poland
Oman
Puerto Rico
Sudan
Guernsey
Cameroon
Andorra
Colombia
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Paraguay
Seychelles
Botswana
Canada
South Africa
France
Georgia
Denmark
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
Senegal
El Salvador
Tanzania
India
Germany
Ireland
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Qatar
Spain
Angola
Europe
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Estonia
Faroe Islands
Jersey
Bahrain
Bahamas
Bolivia
Belize
Algeria
Italy
Finland
Belarus
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech VC Funds & Investors in Middle East (September 2026)

The most active venture capital funds investing in Middle East Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Middle East Biotech startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Trendlines Group
VC Fund
21 Israel, Singapore, United Kingdom Seed, Venture - Series Unknown Health Care, Biotechnology, Medical Device $650k–$62M
Israel Innovation Authority
VC Fund
18 Israel, United States, Mali Grant, Seed, Pre-Seed Health Care, Artificial Intelligence, Biotechnology $100k–$6M
OurCrowd
VC Fund
16 Israel, United States, New Zealand Series B, Series A, Seed Software, Artificial Intelligence, Health Care $604k–$62M
Pontifax
VC Fund
16 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $6.3M–$130M
OrbiMed
VC Fund
11 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $9.8M–$160M
TRANGELS
VC Fund
10 Turkey, United States, Estonia Seed, Pre-Seed, Angel Software, Information Technology, Artificial Intelligence $55k–$1.4M
FutuRx
VC Fund
10 Israel Seed, Venture - Series Unknown Biotechnology, Biopharma, Therapeutics
Docor International Management
VC Fund
9 Israel, United States Series C, Venture - Series Unknown Health Care, Biotechnology, Medical Device $8M–$22M
aMoon Fund
VC Fund
8 United States, Israel, France Series B, Series A, Series C Health Care, Biotechnology, Medical $5.7M–$93M
RMGP Biopharma Investment Fund
VC Fund
7 Israel Seed, Series B, Venture - Series Unknown Biotechnology, Biopharma, Therapeutics
ZORA Ventures
VC Fund
7 Israel, United States, United Kingdom Seed, Series A, Convertible Note Biotechnology, Health Care, Software $1M–$8.6M
Welltech Ventures
VC Fund
7 Israel, United States, Poland Seed, Series A, Venture - Series Unknown Health Care, Artificial Intelligence, mHealth $718k–$20M
HBL Hadasit Bio Holdings
VC Fund
7 Israel Venture - Series Unknown, Seed, Series A Biotechnology, Medical, Health Care $10M–$47M
Arkin Holdings
VC Fund
6 Israel, United States, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2M–$95M
S2G Investments
VC Fund
6 United States, Canada, Israel Series A, Series B, Venture - Series Unknown Food and Beverage, Agriculture, Biotechnology $3.9M–$100M
Egypt Ventures
VC Fund
6 Egypt, United States, The Netherlands Seed, Venture - Series Unknown, Pre-Seed Software, Information Technology, FinTech $28k–$120M
iAngels
VC Fund
5 United States, Israel, United Kingdom Seed, Series A, Pre-Seed Artificial Intelligence, Software, Financial Services $120k–$22M
Sapir Venture Partners
VC Fund
5 Israel, United States, United Kingdom Seed, Pre-Seed, Series A Software, Biotechnology, Analytics $305k–$40M
ALIVE Israel HealthTech Fund
VC Fund
5 Israel, United States Series A, Series C, Venture - Series Unknown Health Care, Medical, Biotechnology $4.4M–$105M
iVentures Asia
VC Fund
5 Israel, Hong Kong, United States Seed, Series A, Series B Software, Biotechnology, Mobile $2M–$18M
Siddhi Capital
VC Fund
5 United States, Israel, Canada Seed, Series A, Pre-Seed Food and Beverage, Biotechnology, AgTech $1M–$21M
Kinisis Ventures
VC Fund
5 Cyprus, United States, United Kingdom Seed, Venture - Series Unknown, Pre-Seed Manufacturing, Energy, 3D Technology $218k–$2.6M
Istcapital
VC Fund
5 Turkey, United States, United Kingdom Seed, Series A Artificial Intelligence, Biotechnology, SaaS $230k–$10M
Consensus Business Group
VC Fund
5 Israel, United States, United Kingdom Series B, Seed Health Care, Medical Device, Medical $1.3M–$80M
Agriline
VC Fund
5 Israel Seed, Series A, Venture - Series Unknown Health Care, Medical, Biotechnology $1.3M–$17M
Diffusion Capital Partners
VC Fund
5 Turkey, United States, United Kingdom Seed, Pre-Seed Software, Information Technology, SaaS $59k–$3M
Milk & Honey Ventures
VC Fund
5 Israel Pre-Seed, Seed, Series A Food and Beverage, Biotechnology, Nutrition $1M–$5.2M
fresh.fund
VC Fund
4 Israel, United States, Norway Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $300k–$21M
Integra Holdings
VC Fund
4 Israel Seed, Series B, Series F Biotechnology, Pharmaceutical, Life Science
Millenium Food-Tech
VC Fund
4 Israel Seed, Series A, Series B Food and Beverage, Manufacturing, Retail $2.5M–$105M
Grove Ventures
VC Fund
4 Israel, United States Seed, Series A, Series B Artificial Intelligence, Software, Machine Learning $3.3M–$74M
Cancer Focus Fund
VC Fund
4 Israel, United States, Germany Venture - Series Unknown, Series A, Seed Biotechnology, Medical, Health Care $4.5M–$47M
New York Ventures
VC Fund
4 United States, Canada, Israel Seed, Series A, Series B Health Care, Biotechnology, Software $1M–$53M
South Israel Bridging Fund
VC Fund
4 Israel, Cyprus, United States Series A, Venture - Series Unknown, Series B Biotechnology, Software, Energy $750k–$34M
Takeda Ventures
VC Fund
4 United States, United Kingdom, Israel Series A, Series B Biotechnology, Health Care, Therapeutics $12M–$130M
GlenRock Israel
VC Fund
4 Israel, United States Seed, Series A, Series B Software, Health Care, Cyber Security $100k–$30M
Tnuva
VC Fund
4 Israel Seed, Series A, Series B Biotechnology, Food and Beverage, Food Processing $1.2M–$6M
Johnson & Johnson Robotics and Digital Solutions
VC Fund
4 United States, Israel, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $300k–$100M
Entrée Capital
VC Fund
4 United States, Israel, United Kingdom Seed, Series A, Series B Software, FinTech, Financial Services $1.5M–$54M
Clal Biotechnology Industries
VC Fund
4 Israel, United States Series A, Series B Health Care, Biotechnology, Medical Device $4M–$55M
Israel Biotech Fund
VC Fund
3 Israel, United States Series A, Series B, Series C Biotechnology, Health Care, Pharmaceutical $9M–$45M
SOSV
VC Fund
3 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
Acasia Group
VC Fund
3 Egypt, United States, Nigeria Seed, Angel, Venture - Series Unknown Mobile, E-Commerce, Financial Services $50k–$2.6M
Pitango VC
VC Fund
3 Israel, United States, United Kingdom Series B, Series A, Series C Software, Health Care, Information Technology $4M–$100M
CPT Capital
VC Fund
3 United States, Israel, United Kingdom Seed, Series A, Series B Food and Beverage, Biotechnology, Food Processing $1.3M–$226M
Tempo Beverages Cyprus Ltd.
VC Fund
3 Israel Venture - Series Unknown, Series A Biotechnology, AgTech, Nutrition $1.5M–$9M
Agrinnovation
VC Fund
3 Israel, France Seed Biotechnology, AgTech, Food Processing $1M–$4.5M
M Ventures
VC Fund
3 United States, United Kingdom, Switzerland Series A, Series B, Seed Biotechnology, Health Care, Therapeutics $2.4M–$100M
Good Seed Ventures
VC Fund
3 Germany, Israel, United States Seed, Series A, Pre-Seed Food and Beverage, Food Processing, Biotechnology $55k–$50M
Tyson Ventures
VC Fund
3 United States, Israel Grant, Series A Food and Beverage, Biotechnology, Software $4M–$37M
Access all 50 VC funds in Middle East Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Trendlines Group
VC Fund · Misgav, HaZafon, Israel · 21 investments in Middle East Biotech startups

Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Seed, Venture - Series Unknown
  • Geography: Israel, Singapore, United Kingdom

Investor stats

  • Total investments: 70
  • Round size: Seed $650k–$4.1M; Venture - Series Unknown $1M–$62M
  • Lead/follow: 21% lead, 79% follow
  • Last fund: May invest from a new fund soon — raised $40M in 2019

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Israel Innovation Authority
VC Fund · Jerusalem, Yerushalayim, Israel · 18 investments in Middle East Biotech startups

The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Biotechnology
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Israel, United States, Mali

Investor stats

  • Total investments: 217
  • Round size: Seed $400k–$6M; Grant $130k–$3.5M; Pre-Seed $100k–$2.1M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — raised $10M in 2023

Portfolio highlights

  • Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
  • PulseNmore — Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.
  • GeoRank Studio — Get your business ranked on Google, cited by ChatGPT & Perplexity, and protected from reputation damage. Specialist SEO and GEO agency. Free consultation.
Show all investments...

OurCrowd
VC Fund · Jerusalem, Yerushalayim, Israel · 16 investments in Middle East Biotech startups

Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: Israel, United States, New Zealand

Investor stats

  • Total investments: 372
  • Round size: Seed $604k–$9.5M; Series A $4.5M–$22M; Series B $7M–$62M
  • Lead/follow: 16% lead, 84% follow
  • Last fund: Likely actively investing — fresh fund, raised $230k in 2026

Portfolio highlights

  • N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
  • Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
  • MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 16 investments in Middle East Biotech startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 122
  • Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $14M in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Crystalys Therapeutics — Transforming care for people living with gout.
  • Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 11 investments in Middle East Biotech startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 740
  • Round size: Series A $9.8M–$140M; Series B $24M–$148M; Series C $19M–$160M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fresh fund, raised $192M in 2026

Portfolio highlights

  • Insilico Medicine — Artificial Intelligence for Drug Discovery and Aging Research
  • Star Therapeutics — Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
  • Affimed — At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim toovercome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
Show all investments...

TRANGELS
VC Fund · Istanbul, Istanbul, Turkey · 10 investments in Middle East Biotech startups

Early Stage Investment Fund and Network

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Angel
  • Geography: Turkey, United States, Estonia

Investor stats

  • Total investments: 60
  • Round size: Seed $67k–$1.4M; Angel $100k–$500k; Pre-Seed $55k–$500k
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Datasance — Securely deploy, manage, and scale containerized workloads across thousands of heterogeneous far-edge and IoT environments.
  • Trawell Data — Trawell Data is a mobile data services company that provides travelers to use mobile data on their mobile phones without changing phones or sim cards. It enables the phone to digitally connect and use the local operator. Trawell Data was established in 2015 and is headquartered in Syosset, New York.
  • Visionteractive — Visionteractive develops social media based, fun and interactive physical and digital products, bridging the gap between online and actual world. The company aims to bring a brand together with the target audience by developing various creative products, while enhancing the memorability owing to the interactive experience with the users.Visionteractive was founded on 2013 and is based in Turkey.
Show all investments...

FutuRx
VC Fund · Ness Ziona, HaMerkaz, Israel · 10 investments in Middle East Biotech startups

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. following winning the tender of the Office of the Chief Scientist (OCS), Ministry of Economy, in Israel.The incubator willadvance new biotechnology products by identifying and nurturing early-stage life science innovation.FutuRx is located in the Weizmann Science Park in Ness Ziona (near the Weizmann Institute), Israel.

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Therapeutics
  • Stage:Seed, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 10
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • A2i Therapeutics — A2i Therapeutics develops novel therapeutic modulators of the protein that helps to control the immune response and neurological disorders.
  • Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
  • Selene Therapeutics — Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by the regulation of the neuronal activity set point by a reduction of the neuronal mean firing rate (MFR).Selene aims to develop small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme located on the inner mitochondrialmembrane and participating in several key cellular homeostatic processes.
Show all investments...

Docor International Management
VC Fund · Tel Aviv, Tel Aviv, Israel · 9 investments in Middle East Biotech startups

Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series C, Venture - Series Unknown
  • Geography: Israel, United States

Investor stats

  • Total investments: 18
  • Round size: Series C $13M–$22M; Venture - Series Unknown $8M–$15M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
  • SP Nano — SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin.
  • Raziel Therapeutics — Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity.
Show all investments...

aMoon Fund
VC Fund · Ra'anana, HaMerkaz, Israel · 8 investments in Middle East Biotech startups

aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 80
  • Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
  • Lead/follow: 49% lead, 51% follow
  • Last fund: Likely still investing — raised $340M in 2022

Portfolio highlights

  • Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
  • Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
  • Hopscotch Primary Care — We provide primary care services to seniors on Medicare, offering more time with your doctor, and a full care team to support all of your healthcare needs.
Show all investments...

RMGP Biopharma Investment Fund
VC Fund · 7 investments in Middle East Biotech startups

RMGP Biopharma Investment Fund is an investment Fund

Show more...

Investment focus

  • Industry: Biotechnology, Biopharma, Therapeutics
  • Stage:Seed, Series B, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Circuit-Bio — Circuit-Bio is a synthetic biology company developing a unique platform of logical gene circuits for cancer immunotherapy. The platform used by the company focuses on creating gene circuits that can precisely and locally manufacture a combination of several immune-stimulating proteins (immunomodulators) that are only expressed in specific tumorcells. The circuit turns cancer cells into "Trojan horses" that are used as anti-tumor resources and incite a potent, long-lasting immune response.
  • Skip Therapeutics — Skip Therapeutics develops precision, RNA-based, treatments for rare genetic diseases. Millions of people worldwide are affected by thousands of rare genetic disorders, yet the limited patient populations, further divided by patient-specific mutations, have hampered the discovery of effective treatments. Recent developments in RNA-therapeuticsprovide an enlarged molecular toolkit that can be used quickly and affordably to repair damaged genes' ability to make proteins. Computational techniques could be used to help identify sub-patient populations that would be eligible for treatment with RNA-based therapeutics and match molecular therapy options across the large landscape of known disease-causing mutations.
  • Selene Therapeutics — Selene Therapeutics is developing a new therapeutic strategy for treating refractory epilepsy by the regulation of the neuronal activity set point by a reduction of the neuronal mean firing rate (MFR).Selene aims to develop small molecule inhibitors of Dihydroorotate dehydrogenase (DHODH), a mitochondrial enzyme located on the inner mitochondrialmembrane and participating in several key cellular homeostatic processes.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
ZORA Ventures
VC Fund · Herzliya, Tel Aviv, Israel · 7 investments in Middle East Biotech startups

Impact investing in Israeli technology. ZORA is an impact investing fund investing in early-stage Israeli companies solving global challenges in health, education, economic inclusion and the environment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Convertible Note
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 17
  • Round size: Seed $1M–$8.6M; Series A $4M–$8.1M
  • Lead/follow: 6% lead, 94% follow
  • Last fund: May invest from a new fund soon — raised $740k in 2020

Portfolio highlights

  • Newmoo — Newmoo makes plant-based cheeses and dairy alternatives.
  • WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
  • Earth Force Technologies — Earth Force is a Vegetation Management System platform.
Show all investments...

Welltech Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 7 investments in Middle East Biotech startups

Welltech Ventures is Israel’s leading fund focused exclusively on investing in the health and wellness space. We seek to partner with entrepreneurs who epitomize the Startup Nation’s ethos and are building paradigm-shattering companies that are making an impact in the wellness space. As thought leaders we work with global investors focused onaccessing and investing in the Israeli tech ecosystem’s most promising entrepreneurs.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, mHealth
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Israel, United States, Poland

Investor stats

  • Total investments: 23
  • Round size: Seed $718k–$19M; Series A $6M–$20M; Venture - Series Unknown $3M–$5.3M
  • Lead/follow: 35% lead, 65% follow

Portfolio highlights

  • MDI Health — Transform Quality Metrics Clinical Outcomes & Costs all inOne Platform. Your AI Co-Pilot for Medication Management
  • Antidote Health — AntidoteHealth.ai offers primary care on its telehealth app on a 24/7 basis, including prescriptions & more. Book your appointment today!
  • Marquee — Marquee turns football data into decision-ready insights in seconds, unifying external and internal data and filtering it through your club's sporting DNA.
Show all investments...

HBL Hadasit Bio Holdings
VC Fund · Jerusalem, Yerushalayim, Israel · 7 investments in Middle East Biotech startups

Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Venture - Series Unknown, Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 11
  • Round size: Venture - Series Unknown $10M–$47M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Show all investments...

Arkin Holdings
VC Fund · Herzliya, Tel Aviv, Israel · 6 investments in Middle East Biotech startups

Explore Arkin Capital: A leading multi-asset manager driving strategic investments across health, technology, equity, real estate and more

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: Israel, United States, Switzerland

Investor stats

  • Total investments: 32
  • Round size: Seed $2M–$6M; Series A $15M–$29M; Series B $23M–$95M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely actively investing — fresh fund, raised $100M in 2026

Portfolio highlights

  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Nocion Therapeutics — Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation. The company is developing "nocions" which are a new kind of therapy that selectively affects actively firing nociceptors, enabling patients to provide targeted, robust and sustained relief for the treatment ofserious conditions including cough, itch, pain and inflammation.
  • Werewolf Therapeutics — Developing transformative conditionally activated proinflammatory immune modulating medicines to unleash a powerful attack on cancer.
Show all investments...

S2G Investments
VC Fund · Chicago, Illinois, United States · 6 investments in Middle East Biotech startups, 15 in the past 12 months

S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.

Show more...

Investment focus

  • Industry: Food and Beverage, Agriculture, Biotechnology
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 227
  • Round size: Series A $4M–$55M; Series B $3.9M–$100M; Venture - Series Unknown $4.3M–$50M
  • Lead/follow: 48% lead, 52% follow
  • Last fund: Likely actively investing — fresh fund, raised $1B in 2026

Portfolio highlights

  • Corvus Robotics — AI-powered autonomous drones and forklift sensors for real-time warehouse inventory visibility. Trusted by Fortune 500 enterprises.
  • SWARM — SWARM is a Software-as-a-Service platform that uses a next generation cognitive computing system, structured around a multi-agent approach which can utilize a cur
  • Kuehnle Agrosystems — Kuehnle AgroSystems curates a unique set of algae originating from pristine waters and ecosystems of Hawaii, as well as tropical botanical accessions representing plants prized by Polynesian voyagers.
Show all investments...

Egypt Ventures
VC Fund · El Cairo, Valle del Cauca, Colombia · 6 investments in Middle East Biotech startups

Egypt Ventures is an investment firm that empowers the entrepreneurial ecosystem by investing in accelerators. The firm was founded in 2017 and is based in Columbia.

Show more...

Investment focus

  • Industry: Software, Information Technology, FinTech
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Egypt, United States, The Netherlands

Investor stats

  • Total investments: 38
  • Round size: Seed $250k–$3M; Pre-Seed $28k–$2M; Venture - Series Unknown $3.2M–$120M
  • Lead/follow: 34% lead, 66% follow

Portfolio highlights

  • Flend — Egypt’s first tech enabled, data driven financing solutions platform dedicated to small businesses.
  • D OCC Hub — Smart Incident Management Solutions
  • InfiniLink — Empowering Hyperscale Datacenters Building Energy-Efficient Ultra-High-Speed Connectivity Solutions
Show all investments...

iAngels
VC Fund · Tel Aviv, Tel Aviv, Israel · 5 investments in Middle East Biotech startups

iAngels is a VC and angel investment platform that leverages due diligence and analytics to enable accredited investors around the world the ability to invest in early-stage technology deals in Israel.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Financial Services
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 138
  • Round size: Seed $900k–$10M; Pre-Seed $120k–$400k; Series A $4.2M–$22M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: May invest from a new fund soon — raised $56M in 2021

Portfolio highlights

  • Nas Daily —
  • Recapp — Recapp is a sports-video platform that creates a single, scrollable feed by compiling and arranging game highlights from various leagues.
  • Lasso Security — Lasso Security defends the LLM frontier with advanced LLM Cybersecurity solutions. Embrace progress and strengthen your AI cybersecurity posture
Show all investments...

Sapir Venture Partners
VC Fund · 5 investments in Middle East Biotech startups

Early Stage VC

Show more...

Investment focus

  • Industry: Software, Biotechnology, Analytics
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 22
  • Round size: Seed $1.3M–$10M; Pre-Seed $305k–$800k; Series A $10M–$40M
  • Lead/follow: 23% lead, 77% follow

Portfolio highlights

  • Enzymit — Enzymit's platform technology can build molecular machines that enable never before seen chemistry aiming to solve humanity's greatest challenges
  • Lidwave — Lidwave’s deep-tech solution revolutionizes 3D sensing and the verticals relying on it by examining the biggest challenge in LiDAR technology from a new perspective, free of bandwidth limitations.
  • DeepCure — DeepCure is a Boston-based therapeutics company that harnesses advanced AI, physics-based tools and automation to discover novel small molecules for challenging targets. DeepCure currently has a lead asset in IND-enabling studies and other programs focused on drugging intractable targets that have t
Show all investments...

ALIVE Israel HealthTech Fund
VC Fund · Tel Aviv, Tel Aviv, Israel · 5 investments in Middle East Biotech startups

ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Series C, Venture - Series Unknown
  • Geography: Israel, United States

Investor stats

  • Total investments: 15
  • Round size: Series A $4.4M–$17M; Series C $30M–$55M; Venture - Series Unknown $11M–$105M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Show all investments...

iVentures Asia
VC Fund · Hong Kong, Hong Kong Island, Hong Kong · 5 investments in Middle East Biotech startups

iVentures Asia is a Hong Kong-based venture capital fund that offers end-to-end support to their portfolio companies. The company was founded by Benjamin Weiss in November 2013.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Mobile
  • Stage:Seed, Series A, Series B
  • Geography: Israel, Hong Kong, United States

Investor stats

  • Total investments: 18
  • Round size: Seed $2M–$2.4M; Series A $4M–$5.5M; Series B $2M–$18M
  • Lead/follow: 6% lead, 94% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • WeedOut — WeedOut: Exploiting Sterility against Resistant Weeds
  • DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
  • Vision Travel AI — Vision Travel AI is a groundbreaking platform based in China, dedicated to transforming the cultural tourism industry through the fusion of VR/AR technologies and artificial intelligence. By recreating historical scenes and providing immersive cultural experiences, Vision Travel AI allows tourists to explore and engage with history like neverbefore.Vision Travel AI utilizes virtual reality (VR) technology to create completely virtual environments. These environments transport tourists back in time, allowing them to experience historical scenes as if they were actually there. When tourists visit historical sites, they can use devices like smartphones or AR glasses to see reconstructions of ruins and historical landmarks. One of the standout features of Vision Travel AI is its interactive guide system, featuring the Guide BOT Digital Human. Upon entering a site, visitors can activate this digital guide to begin an "Ask and Answer Tour." The Guide BOT functions like a real tour guide, offering detailed introductions to artifacts, buildings, and historical contexts. Tourists can interrupt the Guide BOT at any time to ask questions, receiving instant, in-depth answers that expand their knowledge and understanding of the site. Vision Travel AI's innovative approach to cultural tourism transforms the way people connect with history. Vision Travel AI has established partnerships with over 7 historical and cultural sites globally, enhancing visitor experiences through cutting-edge technology. A significant collaboration with Sichuan Province's Dujiangyan Irrigation System, a UNESCO World Heritage site, has brought ancient Chinese engineering marvels to life for visitors through immersive VR/AR experiences.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Siddhi Capital
VC Fund · Cherry Hill, New Jersey, United States · 5 investments in Middle East Biotech startups

Siddhi Capital is the growth equity partner for convention-crushing food and beverage companies.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, AgTech
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 60
  • Round size: Seed $2M–$6.3M; Pre-Seed $1M–$3.6M; Series A $5M–$21M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely actively investing — fresh fund, raised $475k in 2026

Portfolio highlights

  • Nopalera — Vegan, cruelty free, and Latina owned. Handmade cactus products that celebrate culture and resilience.
  • Pigmentum — Pigmentum is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.
  • ProFuse Technology — ProFuse Technology revolutionizes cultured meat production by shortening it duration, improving the meat quality and increasing yields.
Show all investments...

Kinisis Ventures
VC Fund · New York, New York, United States · 5 investments in Middle East Biotech startups

Kinisis Ventures is a venture capital firm backing bold founders building the future. Discover our portfolio, meet our team, and explore how we support startups from seed to scale.

Show more...

Investment focus

  • Industry: Manufacturing, Energy, 3D Technology
  • Stage:Seed, Venture - Series Unknown, Pre-Seed
  • Geography: Cyprus, United States, United Kingdom

Investor stats

  • Total investments: 16
  • Round size: Seed $1.1M–$2.6M; Venture - Series Unknown $218k–$1.4M
  • Lead/follow: 63% lead, 37% follow

Portfolio highlights

  • Phase3D — Phase3D develops in-situ monitoring technology for additive manufacturing, providing real-time, layer-by-layer inspection of 3D printing processes. Their flagship product, Fringe, uses structured light to detect and quantify anomalies during printing, offering data in microns for quality assessment. Fringe is compatible with various industrial 3Dprinters and can be retrofitted to existing equipment. The system helps users identify issues early and take action to maintain part integrity.
  • Autonomics — Autonomics is developing a city cleaning solution to help municipalities make the urban environment a clean, healthy, and cozy place to live with robotics and AI.
  • ProMed BioSciences — Promed is an EU-based, highly innovative biotech company, developing collagen-based biomaterials
Show all investments...

Istcapital
VC Fund · Capelle Aan Den Ijssel, Zuid-Holland, The Netherlands · 5 investments in Middle East Biotech startups

ISTcapital is a family office-backed venture capital firm partnering with exceptional founders to build early-stage, global technology companies.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, SaaS
  • Stage:Seed, Series A
  • Geography: Turkey, United States, United Kingdom

Investor stats

  • Total investments: 15
  • Round size: Seed $230k–$3M; Series A $500k–$10M
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Cellestetix — Cellestetix is a biotech company that specializes in developing and commercializing plant-based exosome formulas for regenerating skin, hair, and wellness.
  • Spline — Spline is a free 3D design software with real-time collaboration to create web interactive experiences in the browser. Easy 3d modeling, animation, textures, and more.
  • PhiTech Bioinformatics — PhiTech pioneers the integration of DNA & RNA sequencing data with AI for rare disease diagnostics. We offer the first RNA-based diagnostic support tool.
Show all investments...

Consensus Business Group
VC Fund · London, England, United Kingdom · 5 investments in Middle East Biotech startups

Acting as advisor to companies within the Tchenguiz Family Trust, Consensus Business Group has amassed a portfolio of over 300,000 residential freeholds worth over £4 billion and a commercial portfolio worth over £2 billion.Consensus Business Group has vast experience and a proven track record of acquiring stock directly from nationalhousebuilders and developers over 20 years.As a result of their strategic investment, Consensus Business Group is believed to be the largest owner and asset manager of residential freehold interests in the UK, representing in excess of 1% of the housing stock in England and 1.2% in Greater London.Their decisions are not subject to procrastinated board approval or credit committees and as a result they are able to perform quickly and consistently. They are not dependent on debt finance and they have immediate cash availability.Consensus Business Group prides itself on having the market knowledge and expertise to stand out from its competitors, and it is their diligent and efficient acquisition practices that ensure swift transactions.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series B, Seed
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 24
  • Round size: Seed $1.3M–$4.5M; Series B $11M–$80M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
  • Synchrony Medical — Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.
  • Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
Show all investments...

Agriline
VC Fund · Bromsgrove, Worcestershire, United Kingdom · 5 investments in Middle East Biotech startups

Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
  • Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
  • SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Show all investments...

Diffusion Capital Partners
VC Fund · Istanbul, Istanbul, Turkey · 5 investments in Middle East Biotech startups

Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.

Show more...

Investment focus

  • Industry: Software, Information Technology, SaaS
  • Stage:Seed, Pre-Seed
  • Geography: Turkey, United States, United Kingdom

Investor stats

  • Total investments: 65
  • Round size: Seed $350k–$3M; Pre-Seed $59k–$1.4M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: May invest from a new fund soon — raised $35M in 2020

Portfolio highlights

  • Etched — Transformers etched into silicon. By burning the transformer architecture into our chips, we're creating the world's most powerful servers for transformer inference.
  • GoWit Technology — Unlock your retail media potential with GoWit's omnichannel Retail Media Advertising platform. Expand your audience reach, optimize bidding, and leverage first-party data for maximum conversions and privacy protection.
  • Mikro Biyosistemler Inc. — Mikro Biyosistemler is a biomedical microsystems company focuses on development of microfluidics and lab-on-a-chip systems for biomedical applications.
Show all investments...

Milk & Honey Ventures
VC Fund · 5 investments in Middle East Biotech startups

Tel-Aviv based investment firm, focused on the effective acceleration of disruptive New Protein technologies

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Nutrition
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Israel

Investor stats

  • Total investments: 6
  • Round size: Seed $3.5M–$5.2M; Pre-Seed $1M–$2.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
  • SuperMeat — SuperMeat is an Israeli bio-tech and food-tech company, developing a technology to create clean meat from chicken cells in a safe and controlled environment, external to the animal’s body. SuperMeat is set to revolutionize the meat industry from its core, aspiring to secure a better future for humans and animals alike. Clean meat is grown in acontrolled, sterile environment without the use of antibiotics and without any possibility of fecal contamination, such as salmonella. Clean meat will require significantly less resources for its production (99% less land, 90% less water), making it both a healthy and sustainable food source for the coming century.
  • Meala Foodtech — Revolutionary texturized plant proteins that replace eggs and hydrocolloids. Clean-label, allergen-free solutions for baking, savory foods, and dressings.
Show all investments...

fresh.fund
VC Fund · Jerusalem, Yerushalayim, Israel · 4 investments in Middle East Biotech startups, 7 in the past 12 months

fresh.fund is an Israeli pre-seed venture capital fund investing in early-stage startups across segments and verticals.We're built to partner with early-stage founders from day one, often as the company's first institutional investors. Our model is refreshingly simple: up to $300,000 in pre-seed funding within <4 weeks and follow-oncapital as necessary.Check out our portfolio here >> https://www.fresh.fund/portfolio. It's never too early to have a conversation about your startup.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Israel, United States, Norway

Investor stats

  • Total investments: 44
  • Round size: Seed $1.6M–$10M; Pre-Seed $300k–$6M; Series A $11M–$21M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely actively investing — fresh fund, raised $7.9M in 2025

Portfolio highlights

  • Kimba — Kimba is an adaptive scent sleep system that uses sleep and biometric data to deliver personalized, natural-origin scents at specific moments throughout the night, designed to actively improve sleep rather than simply track it.
  • CopilotKit — The Enterprise-Ready Frontend Stack for Agents. CopilotKit lets you integrate LLMs or agents with real-time context, UI control, and full flexibility.
  • Shifters AI — Shifters builds autonomous robotic teams for dangerous ground missions.
Show all investments...

Integra Holdings
VC Fund · Wallisellen, Zurich, Switzerland · 4 investments in Middle East Biotech startups

Our expert team is the first to examine and evaluate the Hebrew University's biomedical breakthroughs. We then capitalize decades of experience - transforming the inventions into pioneering companies. Our golden eggs Ayana Pharma A late stage company with

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Life Science
  • Stage:Seed, Series B, Series F
  • Geography: Israel

Investor stats

  • Total investments: 8
  • Lead/follow: 75% lead, 25% follow

Portfolio highlights

  • BacoCure — BacoCure is developing a novel bacterial product for local therapy of non-muscle invasive bladder cancer (NMIBC) patients.
  • Splisense — Transformative RNA Based Treatments -Antisense Oligonucleotides- Targeting the Root Cause of Pulmonary Diseases Our innovative RNA based therapies, based on Antisense Oligonucleotides (ASOs), restore and modify protein functionality, addressing untreatable pulmonary diseases.
  • Rebiotic Rx — Develops nanotechnology-based antibiotics with the focus on resistant bacteria
Show all investments...

Millenium Food-Tech
VC Fund · 4 investments in Middle East Biotech startups

Millennium Food-Tech is an R&D partnership traded on the Tel Aviv Stock Exchange that specializes in investment in and betterment of companies in food-tech sectors,. Millennium seeks to invest in companies that specialize in identifying and developing innovative, and transformative ideas in the food, drinks, and nutrition industry. Millenniumhas experienced management, proven solutions, and a supportive network to develop ideas and start-ups from early-stage to maturity to exit.

Show more...

Investment focus

  • Industry: Food and Beverage, Manufacturing, Retail
  • Stage:Seed, Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 20
  • Round size: Seed $2.5M–$6M; Series A $3M–$15M; Series B $17M–$105M
  • Lead/follow: 65% lead, 35% follow

Portfolio highlights

  • TripleW Group NV — Making Waste History. TripleW upcycles food waste into high-value bioplastic
  • ansā — Ansā is a coffee roasting solution designed specifically for the workplace. It offers a system that enables organizations to roast coffee on-site. The solution focuses on providing fresh coffee tailored to workplace preferences. The industries served include food service and hospitality.
  • Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Grove Ventures
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Middle East Biotech startups, 10 in the past 12 months

Grove Ventures is a leading early-stage venture capital fund in Israel. It partners with seed and early-stage founders

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Machine Learning
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 76
  • Round size: Seed $3.3M–$20M; Series A $8M–$50M; Series B $22M–$74M
  • Lead/follow: 41% lead, 59% follow
  • Last fund: Likely still investing — raised $1.5M in 2024

Portfolio highlights

  • Particula — Particula brings new life into Rubik's cube, dice, and chess using AI, connectivity, and interactivity. Enter a smart games world with modern versions of classics!
  • LimitlessCNC — Limitless CNC is an AI-powered technology intended to improve CNC machining operations. It offers an AI CAM agent that works with NX-CAM to give industry-specific strategies and operations.
  • FormX — California's trusted sustainable builders. FormX delivers fully customized single-family homes, ADUs, and backyard offices built faster with component-based modular construction.
Show all investments...

Cancer Focus Fund
VC Fund · Shreveport, Louisiana, United States · 4 investments in Middle East Biotech startups

Cancer Focus Fund is an oncology-focused investment firm advancing breakthrough cancer therapies by partnering with leading scientists, institutions and early-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Venture - Series Unknown, Series A, Seed
  • Geography: Israel, United States, Germany

Investor stats

  • Total investments: 10
  • Round size: Series A $5.4M–$28M; Venture - Series Unknown $4.5M–$47M
  • Lead/follow: 60% lead, 40% follow
  • Last fund: Likely actively investing — fresh fund, raised $23M in 2025

Portfolio highlights

  • KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
  • March Biosciences — Transforming Patient Care by Unlocking New Target Spaces march.biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity of
  • Starget Pharma — Starget Pharma develops a new generation of targeted radiopharmaceutical technologies for the treatment of solid tumors. Starget Pharma has a pipeline of novel targeted radiopharmaceutical molecules that act as a vector for selectively transferring radioisotopes to cancer tumor tissues.
Show all investments...

New York Ventures
VC Fund · New York, New York, United States · 4 investments in Middle East Biotech startups

New York Ventures is dedicated to encouraging innovation and fueling economic growth in communities across the State. This venture capital investment arm of Empire State Development is one of New York State's business resources and innovation investments, including the Governor's START-UP NY program, Innovation Hot Spots, the RegionalEconomic Development Councils, the Centers of Advanced Technology and Centers of Excellence networks, and the SUNY 2020 Initiative.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Israel

Investor stats

  • Total investments: 158
  • Round size: Seed $1M–$6.2M; Series A $3M–$20M; Series B $4M–$53M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Adro — Designed to work when you arrive Spend and save like a local. Easy to use. No unfair fees.
  • BQP — At BQP, we’re developing a quantum-accelerated digital twin platform for mission-critical applications. The platform, BQPhy, is a back-end engine that integrates seamlessly into existing engineering workflows and operates on today’s infrastructure without requiring quantum hardware. BQPhy helps teams solve large-scale, complex challenges inengineering optimization, data-driven modeling (ML), and physics-based (CFD) simulations. We are bridging the gap between current high-performance computers and future quantum systems with probabilistic algorithms from quantum information science, unlocking simulation capabilities that were previously impractical or impossible. BQPhy reduces time, accuracy, and throughput inefficiencies, thereby accelerating development cycles, unlocking previously unexplored design spaces, lowering costs, and enhancing product outcomes.
  • CryoBio — CryoBio offers a food-safe spray solution to protect crops from extreme frost, reducing losses and replacing manual labor with effective, biodegradable frost protection technology.
Show all investments...

South Israel Bridging Fund
VC Fund · Be'er Sheva, HaDarom, Israel · 4 investments in Middle East Biotech startups

South Israel Bridging Fund is a venture capital firm.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Energy
  • Stage:Series A, Venture - Series Unknown, Series B
  • Geography: Israel, Cyprus, United States

Investor stats

  • Total investments: 23
  • Round size: Series A $1.5M–$34M; Series B $7M–$25M; Venture - Series Unknown $750k–$2M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: May invest from a new fund soon — raised $200M in 2020

Portfolio highlights

  • Gadfin — Gadfin design and develops long-range Urgent-delivery systems of the future, which is no less than a game-changer for the Medical and Time-critical deliveries market. Its system brings together traditional flight knowledge, unmanned and autonomy technology, thus redefining delivery capabilities in terms of flight radius, safety, reliability, andautomation, that is going to disrupt the world.
  • Stargo — AI powered routing, pricing and payment solutions for the freight industry
  • Electriq Global — Electriq is a hydrogen carrier that acts like coffee powder for a coffee machine - simplifying storage, transport, and use of hydrogen in off-grid applications and long-term storage.
Show all investments...

Takeda Ventures
VC Fund · San Diego, California, United States · 4 investments in Middle East Biotech startups

Takeda Ventures, Inc. (TVI) is the corporate investment arm of Takeda Pharmaceutical Company Limited (TPC). TVI was founded in 2001 and invests in current and future areas of interest for TPC. They are based alongside Takeda’s R&D sites in Cambridge, MA, and San Diego, CA. As a strategic investor, TVI aims to provide support and guidance toentrepreneurs and early-stage companies driving concepts through clinical proof of concept. They also strive to forge active, collaborative interactions that result in synergies with Takeda's considerable R&D resources. Their goal is to build a portfolio of strategic investments, with an immediate emphasis on oncology, gastroenterology, neuroscience, and rare diseases.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B
  • Geography: United States, United Kingdom, Israel

Investor stats

  • Total investments: 104
  • Round size: Series A $12M–$58M; Series B $20M–$130M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
  • Accipiter Biosciences — Accipiter Biosciences is a biotechnology company.
  • Harness Therapeutics — Transine Therapeutics is a private biotechnology company focused on the development of a novel class of therapeutic RNAs that can upregulate protein expression with an unprecedented level of control and specificity: the SINEUPs®. The company's pioneering technology is expected to offer an entirely unique mechanism of action for currentlyhard-to-treat diseases by massively extending the druggable proteome and allowing it to address diseases that have been beyond the reach of small molecules, conventional biologics, or gene therapies.
Show all investments...

GlenRock Israel
VC Fund · Herzliya, Tel Aviv, Israel · 4 investments in Middle East Biotech startups

A Private Equity Investment Company Founded by Leon Recanati in 2003, GlenRock leverages a unique combination of private equity, multidisciplinary in-house expertise, unmatched access to quality dealflow, and a focused but flexible investment strategy to achieve maximum returns.

Show more...

Investment focus

  • Industry: Software, Health Care, Cyber Security
  • Stage:Seed, Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 37
  • Round size: Seed $1M–$9M; Series A $1.5M–$12M; Series B $100k–$30M
  • Lead/follow: 3% lead, 97% follow

Portfolio highlights

  • Treetoscope — The first and only commercial device that senses the internal water flow of a plant and directly measures its water consumption and real-time irrigation needs. without extrapolations based on indirect sensing technologies.Treetoscope offers a SaaS irrigation management platform, based on direct plant sensing technology. We tackle one of the mostcrucial challenges farmers face today: water scarcity and irrigation optimization. Our groundbreaking ag-tech enables the unprecedented measurement of real-time actual water use of trees (based on our patented single probe Sap Flow sensor). Through the Treetoscope solution, growers gain great value as a result of the affordability, scalability, and ease of deployment of our technology.
  • MSICS Pharma — MSICS Pharma is a pharmaceutical company that manufactures and produce naturally-sourced Psilocybin for medical purpose.
  • Quris — Quris Technologies is a bio-AI clinical-prediction platform is being developed to assure the safety and efficacy of medications.The company provides a fully automated, self-training AI platform accurately predicts clinical safety and efficacy for novel drugs faster and more cost-effectively while minimizing animal testing, allowing pharmacompanies to avoid the enormous risks and costs of failed clinical trials and end the reliance on ineffective animal testing.Quris Technologies was established in 2019 by Isaac Bentwich in Tel Aviv, Israel.
Show all investments...

Tnuva
VC Fund · Glil Yam, Tel Aviv, Israel · 4 investments in Middle East Biotech startups

On the Tnuva website you will find information about the Company, its subsidiaries, press releases, the Program for Better Nutrition, contacting customer service and more.

Show more...

Investment focus

  • Industry: Biotechnology, Food and Beverage, Food Processing
  • Stage:Seed, Series A, Series B
  • Geography: Israel

Investor stats

  • Total investments: 6
  • Round size: Seed $1.2M–$6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Pigmentum — Pigmentum is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.
  • Ever After Foods — We produce slaughter-free meats that prevent animal cruelty, and support health, security and sustainability for our planet and its people.
  • ProFuse Technology — ProFuse Technology revolutionizes cultured meat production by shortening it duration, improving the meat quality and increasing yields.
Show all investments...

Johnson & Johnson Robotics and Digital Solutions
VC Fund · New Brunswick, New Jersey, United States · 4 investments in Middle East Biotech startups

Healthcare innovation wherever it originates.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 80
  • Round size: Series A $5.9M–$63M; Series B $18M–$55M; Series C $300k–$100M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Moon Surgical — Create the OR of the future, one that is sustainable, efficient, and digitalized.
  • Manus Neurodynamica — Manus Neurodynamica is a triage device to support early diagnostics in Parkinson's disease.
  • Glyphic Biotechnologies — We sequence proteins. Glyphic Biotechnologies is decoding the human proteome through full coverage, de novo protein sequencing at single molecule resolution to enable the development of novel therapeutics and diagnostics and, ultimately, a deeper understanding of life itself.
Show all investments...

Entrée Capital
VC Fund · London, England, United Kingdom · 4 investments in Middle East Biotech startups

We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.

Show more...

Investment focus

  • Industry: Software, FinTech, Financial Services
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 306
  • Round size: Seed $1.5M–$15M; Series A $5M–$30M; Series B $17M–$54M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely actively investing — fresh fund, raised $175M in 2025

Portfolio highlights

  • Classiq Technologies — A software platform that helps users create scalable complex quantum computer algorithms, software, and circuits for any gate-based quantum computer
  • Identiq — Identiq's network members fight fraud and improve user experience by validating new users and vouching for ones they already know without sharing any personal user data at all.
  • Archy — SaaS Practice Management Software for Dental Practices
Show all investments...

Clal Biotechnology Industries
VC Fund · Tel Aviv, Tel Aviv, Israel · 4 investments in Middle East Biotech startups

Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series B
  • Geography: Israel, United States

Investor stats

  • Total investments: 18
  • Round size: Series A $4M–$55M; Series B $15M–$40M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
  • Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
  • Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Israel Biotech Fund
VC Fund · Rehovot, HaMerkaz, Israel · 3 investments in Middle East Biotech startups

Israel Biotech Fund – Building the future of Israeli BiotechIsrael Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies.Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages.Ourpartners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals.Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support.We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance.We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities.The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Pharmaceutical
  • Stage:Series A, Series B, Series C
  • Geography: Israel, United States

Investor stats

  • Total investments: 15
  • Round size: Series A $9M–$25M; Series B $17M–$30M; Series C $19M–$45M
  • Lead/follow: 67% lead, 33% follow
  • Last fund: May invest from a new fund soon — raised $65M in 2019

Portfolio highlights

  • Ukko — Our mission is to improve the lives of the millions that suffer from food allergies and gluten-related disorders
  • Vensica Medical — Currently, after surgical removal of tumors found in the bladder, a drug is instilled into the bladder via a catheter. This treatment method is inefficient and ineffective: Urinary bladder cancer has the highest recurrence rates among all types of cancer (70%).Using Vensica’s device, the drug will be instilled in a quick, pain-free proceduresubsequent to the delivery of ultrasound to the urinary bladder. Ultrasound improves the uptake of the drug and its penetration into the bladder wall and is expected to improve the treatment and reduce recurrence rates.
  • Nectin Therapeutics — NectinTX develops next-generation delivery platforms for immuno-oncology and precision therapeutics. Discover breakthrough protein expression technologies that power safer, more effective treatments.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 3 investments in Middle East Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

Acasia Group
VC Fund · Cairo, Al Qahirah, Egypt · 3 investments in Middle East Biotech startups

Cairo Angels is an angel investment network that invests in and supports early-stage startups it convenes regular investment meetings to review pre-selected potential investees.

Show more...

Investment focus

  • Industry: Mobile, E-Commerce, Financial Services
  • Stage:Seed, Angel, Venture - Series Unknown
  • Geography: Egypt, United States, Nigeria

Investor stats

  • Total investments: 43
  • Round size: Seed $50k–$2.6M; Angel $200k–$300k
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely still investing — raised $1M in 2022

Portfolio highlights

  • Bosta — Bosta provides an on-demand courier app with a B2C focus, allowing users to send parcels to their customers. The platform connects its users to couriers and allows them to monitor the status of the delivery of the package. Bosta was founded in 2017 and is headquartered in Cairo, Al Qahirah, Egypt.
  • EFG EV Fintech — EFG EV Fintech is investing in startups and bolstering the Fintech ecosystem in the process. EFG EV Fintech combines the financial know-how of EFG Hermes and entrepreneurial expertise of Egypt Ventures to launch the a Fintech-focused startup accelerator.They invest in rising Fintech startups with the potential to grow domestically and expandbeyond the Egyptian market. EFG EV Fintech also provides innovators with the fully integrated services they need to thrive – from funding to mentorship, to training, and office space.
  • Tagaddod — Tagaddod is a renewable Energy and Waste Management Egyptian company, started in February 2013 and operating in Cairo –Egypt. Currently focusing on clean fuels, Tagaddod is working on Biodiesel production from Vegetable Oils. Biodiesel is a fuel alternative that is produced from waste vegetable oils and used in conventional diesel engines, whichcan directly substitute for or extend supplies of traditional petroleum diesel.
Show all investments...

Pitango VC
VC Fund · Herzliya, Tel Aviv, Israel · 3 investments in Middle East Biotech startups

Pitango VC is a venture capital firm focused on health-tech (Pitango Health-tech) and growth (Pitango Growth) investments in startups around the world in domains such as vertical SaaS, digital health, deep tech, fintech and insurance technology, devops, generative AI, Web3, and food tech.With two offices in Israel, Pitango currently managesseveral venture funds totaling over $2.8 billion in committed capital. It has invested in more than 250 companies.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series B, Series A, Series C
  • Geography: Israel, United States, United Kingdom

Investor stats

  • Total investments: 327
  • Round size: Series A $4M–$47M; Series B $8.1M–$55M; Series C $7.8M–$100M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Convizit — Convizit's AI automatically captures user actions, adds properties, and delivers this behavioral data directly into your analytics and marketing platforms.
  • Catch — Catch is the trusted AI Executive Assistant that actually gets work done.
  • QuantHealth — Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services.
Show all investments...

CPT Capital
VC Fund · London, England, United Kingdom · 3 investments in Middle East Biotech startups

Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Food Processing
  • Stage:Seed, Series A, Series B
  • Geography: United States, Israel, United Kingdom

Investor stats

  • Total investments: 63
  • Round size: Seed $1.3M–$7M; Series A $6M–$50M; Series B $16M–$226M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
  • Xias Bio — Mitigate risk with flexible licensing options. Partner with us to transform your ideas into high-performance innovations optimized for efficacy and differentiation.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
Show all investments...

Tempo Beverages Cyprus Ltd.
VC Fund · Limassol, Limassol, Cyprus · 3 investments in Middle East Biotech startups

Tempo Beverages Cyprus Ltd. is a producer and distributor of alcoholic and non-alcoholic beverages and the leading wine grower and wine producer in Israel. Tempo Beverages Cyprus Ltd is a subsidiary company of Tempo Israel, which is partially owned by Heineken NV Group.

Show more...

Investment focus

  • Industry: Biotechnology, AgTech, Nutrition
  • Stage:Venture - Series Unknown, Series A
  • Geography: Israel

Investor stats

  • Total investments: 3
  • Round size: Venture - Series Unknown $1.5M–$9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Remilk — Remilk is a food-tech company that uses microbes to produce the key ingredients in milk. The company is developing technology for creating a milk substitute that is similar to cow milk in flavor, nutritional composition, composition, and functionality. It was founded in 2019 and is based in Tel Aviv, Israel.
  • Pigmentum — Pigmentum is an ag-tech firm developing a molecular technology platform that enables external gene activation in plants.
  • ProFuse Technology — ProFuse Technology revolutionizes cultured meat production by shortening it duration, improving the meat quality and increasing yields.
Show all investments...

Agrinnovation
VC Fund · Jerusalem, Yerushalayim, Israel · 3 investments in Middle East Biotech startups

Agrinnovation is a one-of-a-kind investment fund. While remaining steadfastly independent in all business related issues, the fund has exclusive access and first commercial rights to invest in IP developed in the Faculty of Agriculture, Food and Environment of Israel’s elite academic institution, the Hebrew University of Jerusalem. This exclusivestatus grants us extra time to perform a deeper probe into the new technologies and to bring them from lab to market more swiftly, securely and freely.Backed by an experienced SAB, they work closely with HU scientists and researchers to thoroughly test the technological applicability, scalability and patentability of each breakthrough. Once the technology has proven viable, together with their accomplished Commercial Advisory Board, they meticulously research and test the commercial feasibility of the project before investing and turning it into commercial start-up.Agrinnovation was founded in 2015 by Yissum, the distinguished technology transfer company of the Hebrew University of Jerusalem with over 2 billion dollars in annual sales. Shareholders also include VBS Agri Ventures Pty Ltd., Provident Fund of The Hebrew University of Jerusalem Ltd. and Kingenta Livnat Agriscience Development. The fund is managed by Dr. Ido Schechter, who brings with him decades of business experience in hi-tech and agritech.

Show more...

Investment focus

  • Industry: Biotechnology, AgTech, Food Processing
  • Stage:Seed
  • Geography: Israel, France

Investor stats

  • Total investments: 4
  • Round size: Seed $1M–$4.5M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $52M in 2018

Portfolio highlights

  • Sufresca — Sufresca develops safe-to-consume vegetable and fruit coating intended to increase the shelf life of such products. It designs edible fruit and vegetable coating solutions to reduce food waste and curb the need for plastic packages. Start date of operation - 01-01-2020
  • Hyperplan — Digital agriculture platform for enterprise agribusiness teams. Field-level crop intelligence & in-season signals to size markets, manage risk, and act faster.
  • Believer Meats — Believer is the first food technology company making real, delicious, non-GMO cultivated meat accessible to all.
Show all investments...

M Ventures
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 3 investments in Middle East Biotech startups

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Seed
  • Geography: United States, United Kingdom, Switzerland

Investor stats

  • Total investments: 187
  • Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $13M–$100M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
  • Quintessent — Quintessent is developing optical connectivity solutions to scale computing and Artificial Intelligence (A.I.).
  • TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
Show all investments...

Good Seed Ventures
VC Fund · Rheine, Nordrhein-Westfalen, Germany · 3 investments in Middle East Biotech startups

Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.

Show more...

Investment focus

  • Industry: Food and Beverage, Food Processing, Biotechnology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, Israel, United States

Investor stats

  • Total investments: 39
  • Round size: Seed $55k–$7M; Series A $7.5M–$50M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
  • Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
  • Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Show all investments...

Tyson Ventures
VC Fund · Springdale, Arkansas, United States · 3 investments in Middle East Biotech startups

Tyson Ventures is the investment arm of Tyson Foods. We aim to be the strategic partner of choice for disruptive innovators transforming the food industry, and provide sustainable nutrition to a growing global population. Our current areas of interest focus on emerging proteins, technology enablers and sustainability. Let’s build the future offood... together.

Show more...

Investment focus

  • Industry: Food and Beverage, Biotechnology, Software
  • Stage:Grant, Series A
  • Geography: United States, Israel

Investor stats

  • Total investments: 40
  • Round size: Series A $4M–$37M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — raised $150M in 2016

Portfolio highlights

  • Athian — Funding livestock sustainability via a connected carbon marketplace.
  • Orderful — Gain full control to onboard, manage and resolve all of your EDI trading partner relationships and transactions in real-time.
  • Pactum — Pactum autonomous negotiations help companies unlock hidden value. Our AI negotiates non-strategic supplier contracts on a massive scale.
Show all investments...

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 48,091 VC funds investing in Middle East Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists